Genital Diseases, Female  >>  Camtobell (belotecan)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Camtobell (belotecan) / Equisnzaroo
NCT01630018: Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial

Completed
2b
141
RoW
Topotecan, Hycamtin inj., Belotecan, Camtobell inj.
Chong Kun Dang Pharmaceutical
Epithelial Ovarian Cancer
06/14
06/14

Download Options